Abstract
To assess the magnitude of difference in all-cause healthcare resource utilization (HCRU) and costs between patients with type 2 diabetes mellitus (T2DM) who died from a cardiovascular disease (CVD)-related cause in the year preceding death vs. those who did not die during this same period. A large US administrative claims database was used to identify patients with T2DM who died of a CVD-related cause from July 2012 to April 2015. These patients were matched 1:1 to patients with T2DM who did not die, using direct matching methods. HCRU and costs were assessed in each of the four quarters (Q4: 12-10 months; Q3: 9-7 months; Q2: 6-4 months; and Q1: 3-0 months) prior to death and compared between patient cohorts using paired t-tests and McNemar's tests. A final matched cohort of 7648 patients who died and 7648 patients who did not die were identified. A significantly higher proportion of patients who died utilized inpatient services vs. those who did not die (Q4: 12.6% vs. 4.6%, p < .001; Q3: 14.6% vs. 4.6%, p < .001; Q2: 17.6% vs. 5.5%, p < .001; and Q1: 65.0% vs. 10.1%, p < .001). In addition, patients who died incurred significantly higher all-cause costs (Q4: $8882 vs. $3970, p < .001; Q3: $10,462 vs. $3661, p < .001; Q2: $12,...Continue Reading
References
May 1, 1992·American Journal of Epidemiology·S WacholderJ S Mandel
Mar 23, 2002·Annual Review of Public Health·Thomas LumleyLu Chen
Nov 25, 2004·Diabetes Care·Amie T JoyceCharles M Alexander
Jul 20, 2006·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Leif I SolbergPatrick J O'Connor
Jan 30, 2008·Pharmacotherapy·Mark A Malesker
Sep 28, 2010·Statistical Science : a Review Journal of the Institute of Mathematical Statistics·Elizabeth A Stuart
Oct 13, 2010·Archives of Internal Medicine·Kathleen T UnroeLesley H Curtis
Mar 8, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Aug 21, 2013·American Journal of Preventive Medicine·Xiaohui ZhuoThomas J Hoerger
Sep 3, 2013·The New England Journal of Medicine·Benjamin M SciricaUNKNOWN SAVOR-TIMI 53 Steering Committee and Investigators
Sep 3, 2013·The New England Journal of Medicine·William B WhiteUNKNOWN EXAMINE Investigators
Apr 3, 2015·Circulation. Heart Failure·Shannon M DunlayVéronique L Roger
Jul 15, 2015·Circulation·Matthew A CavenderUNKNOWN REACH Registry Investigators*
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators
Dec 3, 2015·The New England Journal of Medicine·Marc A PfefferUNKNOWN ELIXA Investigators
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Sep 17, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN SUSTAIN-6 Investigators
Nov 25, 2016·Journal of Managed Care & Specialty Pharmacy·Engels N ObiAylin Altan
Jun 13, 2017·The New England Journal of Medicine·Bruce NealUNKNOWN CANVAS Program Collaborative Group
Dec 10, 2017·Diabetes Care
Citations
Dec 24, 2018·Journal of Medical Economics·Rhiannon KamstraPatrick Lefebvre
Jan 10, 2020·Current Medical Research and Opinion·Ameur M ManceurPatrick Lefebvre
Jul 10, 2020·European Heart Journal. Cardiovascular Pharmacotherapy·Bin Wu, Lizheng Shi
May 21, 2021·Frontiers in Pharmacology·Xin CaiXinghua Liao